MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Portfolio Companies: WRF
Alder BioPharmaceuticals (NASDAQ:ALDR)
Finance & Acquisitions: Alder
Parents
Alder BioPharmaceuticals (NASDAQ:ALDR)
Children
2007: Series C closed with $40 million back in 2007
2019: Migraine drugmaker Alder Biopharmaceuticals to be acquired for nearly $2B by Lundbeck – GeekWire
BMS's upfront plus some near-term milestones leaves Alder with enough cash to roll ahead well into 2014
Bringing the total haul to $67 million.
Bristol-Myers Squibb forked over $85 million as a down payment on their $1.07 billion pact covering Alder's lead program, ALD518, an IL-6 inhibitor for rheumatoid arthritis.
Venture backers: Sevin Rosen Funds, Ventures West Management, WRF Capital, H.I.G. Ventures, Delphi Ventures and TPG Biotech
Jumps
*Key People: Alder
Organization & Developments: Alder